{
    "condition": "Depression",
    "description": "Overview of treatment options for Depression.",
    "subclasses": [
        {
            "name": "Pharmacotherapy",
            "description": "Treatment options for Depression.",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "Citalopram",
                            "drugclass": "SSRI",
                            "dose": "20-40 mg",
                            "LOE": "1",
                            "Cognitive Dysfunction": "2",
                            "Fatigue": "2",
                            "notes": "Monitor QTc",
                            "Acceptability": "1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1",
                            "Weight Gain": "1",
                            "Sexual Dysfunction": "-1"
                        },
                        {
                            "name": "Escitalopram",
                            "drugclass": "SSRI",
                            "dose": "10-20 mg",
                            "LOE": "1",
                            "Cognitive Dysfunction": "2",
                            "Fatigue": "2",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1",
                            "Sedation": "1",
                            "Weight Gain": "1",
                            "Sexual Dysfunction": "-1",
                            "Other Tolerability": "1"
                        },
                        {
                            "name": "Fluoxetine",
                            "drugclass": "SSRI",
                            "dose": "20-60 mg",
                            "LOE": "1",
                            "Cognitive Dysfunction": "2",
                            "Fatigue": "2",
                            "Efficacy": "1",
                            "Acceptability": "-1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1",
                            "Sedation": "1",
                            "Weight Gain": "-1",
                            "Sexual Dysfunction": "1",
                            "Other Tolerability": "1"
                        },
                        {
                            "name": "Fluvoxamine",
                            "drugclass": "SSRI",
                            "dose": "100-300 mg",
                            "LOE": "1",
                            "Cognitive Dysfunction": "2",
                            "Fatigue": "2",
                            "Acceptability": "-1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1",
                            "Sedation": "1",
                            "Weight Gain": "-1",
                            "Sexual Dysfunction": "1"
                        },
                        {
                            "name": "Paroxetine",
                            "drugclass": "SSRI",
                            "dose": "20-50 mg",
                            "LOE": "1",
                            "Cognitive Dysfunction": "2",
                            "Fatigue": "2",
                            "Efficacy": "1",
                            "Drug Interactions": "-1",
                            "Discontinuation Syndrome": "-1",
                            "Sedation": "-1",
                            "Weight Gain": "-1",
                            "Sexual Dysfunction": "-1"
                        },
                        {
                            "name": "Sertraline",
                            "drugclass": "SSRI",
                            "dose": "50-200 mg",
                            "LOE": "1",
                            "Cognitive Dysfunction": "2",
                            "Fatigue": "2",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Discontinuation Syndrome": "1",
                            "Weight Gain": "1",
                            "Sexual Dysfunction": "1"
                        },
                        {
                            "name": "Desvenlafaxine",
                            "drugclass": "SNRI",
                            "dose": "50-100 mg",
                            "LOE": "1",
                            "Pain": "2",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1",
                            "Sedation": "1",
                            "Weight Gain": "1",
                            "Sexual Dysfunction": "1"
                        },
                        {
                            "name": "Duloxetine",
                            "drugclass": "SNRI",
                            "dose": "60-120 mg",
                            "LOE": "1",
                            "Pain": "1",
                            "Fatigue": "2",
                            "Cognitive Dysfunction": "2",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "-1"
                        },
                        {
                            "name": "Levomilnacipran",
                            "drugclass": "SNRI",
                            "dose": "40-120 mg",
                            "LOE": "1",
                            "Pain": "2",
                            "notes": "Not Available in Canada",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1"
                        },
                        {
                            "name": "Venlafaxine-XR",
                            "drugclass": "SNRI",
                            "dose": "75-225 mg",
                            "LOE": "1",
                            "Pain": "2",
                            "notes": "",
                            "Efficacy": "1",
                            "Acceptability": "-1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "-1",
                            "Sedation": "-1",
                            "Weight Gain": "-1",
                            "Sexual Dysfunction": "",
                            "Other Tolerability": ""
                        },
                        {
                            "name": "Bupropion",
                            "drugclass": "NDRI",
                            "dose": "150-450 mg",
                            "LOE": "1",
                            "Fatigue": "1",
                            "Cognitive Dysfunction": "2",
                            "notes": "",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1",
                            "Sedation": "1",
                            "Weight Gain": "1",
                            "Sexual Dysfunction": "1",
                            "Other Tolerability": "1"
                        },
                        {
                            "name": "Mirtazapine",
                            "drugclass": "Î±2 antagonist; 5-HT2 antagonist",
                            "dose": "30-60 mg",
                            "LOE": "1",
                            "Sleep": "2",
                            "notes": "",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1",
                            "Sedation": "-1",
                            "Weight Gain": "-1",
                            "Sexual Dysfunction": "1",
                            "Other Tolerability": ""
                        },
                        {
                            "name": "Vilazodone",
                            "drugclass": "SRI; 5-HT1A agonist",
                            "dose": "20-40 mg",
                            "LOE": "1",
                            "notes": "",
                            "Efficacy": "1",
                            "Acceptability": "",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1",
                            "Sedation": "1",
                            "Weight Gain": "1",
                            "Sexual Dysfunction": "1",
                            "Other Tolerability": ""
                        },
                        {
                            "name": "Vortioxetine",
                            "drugclass": "SRI; 5-HT1A, 5-HT1B agonist; 5-HT1D, 5-HT3A, 5-HT7 antagonist",
                            "dose": "10-20 mg",
                            "LOE": "1",
                            "Cognitive Dysfunction": "1",
                            "notes": "",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "1",
                            "Sedation": "1",
                            "Weight Gain": "1",
                            "Sexual Dysfunction": "1",
                            "Other Tolerability": "1"
                        },
                        {
                            "name": "Agomelatine",
                            "drugclass": "MT1, MT2 agonist; 5-HT2 antagonist",
                            "dose": "25-50 mg",
                            "LOE": "1",
                            "Sleep": "1",
                            "notes": "Not Available in Canada; Monitor LFTs",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Drug Interactions": "1",
                            "Discontinuation Syndrome": "",
                            "Sedation": "1",
                            "Weight Gain": "1",
                            "Sexual Dysfunction": "1",
                            "Other Tolerability": ""
                        },
                        {
                            "name": "Mianserin",
                            "drugclass": "Î±2 antagonist; 5-HT2 antagonist",
                            "dose": "30-90 mg",
                            "LOE": "1",
                            "notes": "Not Available in Canada",
                            "Efficacy": "1",
                            "Acceptability": "",
                            "Drug Interactions": "-1",
                            "Discontinuation Syndrome": "",
                            "Sedation": "",
                            "Weight Gain": "",
                            "Sexual Dysfunction": "1",
                            "Other Tolerability": ""
                        },
                        {
                            "name": "Milnacipran",
                            "drugclass": "SNRI",
                            "dose": "30-90 mg",
                            "LOE": "1",
                            "notes": "Not Available in Canada",
                            "Efficacy": "1",
                            "Acceptability": "1",
                            "Drug Interactions": "",
                            "Discontinuation Syndrome": "",
                            "Sedation": "",
                            "Weight Gain": "",
                            "Sexual Dysfunction": "",
                            "Other Tolerability": ""
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Amitryptyline",
                            "drugclass": "TCA",
                            "dose": "75-300 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Clomipramine",
                            "drugclass": "TCA",
                            "dose": "150-300 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Desipramine",
                            "drugclass": "TCA",
                            "dose": "100-300 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Doxepin",
                            "drugclass": "TCA",
                            "dose": "75-300 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Imipramine",
                            "drugclass": "TCA",
                            "dose": "75-300 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Nortryptyline",
                            "drugclass": "TCA",
                            "dose": "75-150 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Protriptyline",
                            "drugclass": "TCA",
                            "dose": "30-60 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Trimipramine",
                            "drugclass": "TCA",
                            "dose": "75-300 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Moclobemide",
                            "drugclass": "RIMA",
                            "dose": "150-450 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Trazodone",
                            "drugclass": "SRI; 5-HT2 antagonist",
                            "dose": "150-400 mg",
                            "LOE": "1",
                            "Sleep": "2"
                        },
                        {
                            "name": "Quetiapine",
                            "drugclass": "DA, 5-HT, Î±1 & Î±2 antagonist; NRI",
                            "dose": "150-300 mg",
                            "LOE": "1",
                            "Sleep": "2"
                        },
                        {
                            "name": "Dextromethorphan-Bupropion",
                            "drugclass": "NMDA antagonist; NDRI, sigma-1 agonist",
                            "dose": "45/105-90/210 mg",
                            "LOE": "2",
                            "notes": "Not Available in Canada"
                        },
                        {
                            "name": "Nefazodone",
                            "drugclass": "SRI, 5-HT2 antagonist",
                            "dose": "300-600 mg",
                            "LOE": "1",
                            "notes": "Not Available in Canada"
                        },
                        {
                            "name": "Selegiline transdermal",
                            "drugclass": "MAO-B inhibitor",
                            "dose": "6-12 mg",
                            "LOE": "2",
                            "notes": "Not Available in Canada"
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Phenelzine",
                            "drugclass": "MAO inhibitor",
                            "dose": "45-90 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Tranylcypromine",
                            "drugclass": "MAO inhibitor",
                            "dose": "30-60 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Reboxetine",
                            "drugclass": "NRI",
                            "dose": "8-12 mg",
                            "LOE": "1",
                            "notes": "Not Available in Canada"
                        }
                    ]
                }
            ]
        },
        {
            "name": "Adjust Pharmacotherapy", 
            "description": "",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "Aripiprazole",
                            "dose": "2-10 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Brexpiprazole",
                            "dose": "0.5-2 mg",
                            "LOE": "1"
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Bupropion",
                            "dose": "150-450 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Intranasal esketamine",
                            "dose": "56-84 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "IV racemic ketamine",
                            "dose": "0.5-1.0 mg/kg",
                            "LOE": "1"
                        },
                        {
                            "name": "Olanzapine",
                            "dose": "2.5-10 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Quetiapine-XR",
                            "dose": "150-300 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Risperidone",
                            "dose": "1-3 mg",
                            "LOE": "1"
                        },
                        {
                            "name": "Lithium",
                            "dose": "600-1200 mg (0.5-0.8 mmol/L)",
                            "LOE": "1"
                        },
                        {
                            "name": "Cariprazine",
                            "dose": "1.5-3 mg",
                            "LOE": "2"
                        },
                        {
                            "name": "Mirtazapine",
                            "dose": "30-60 mg",
                            "LOE": "2"
                        },
                        {
                            "name": "Mianserin",
                            "dose": "30-90 mg",
                            "LOE": "2"
                        },
                        {
                            "name": "Modafinil",
                            "dose": "100-400 mg",
                            "LOE": "2"
                        },
                        {
                            "name": "Triiodothyronine",
                            "dose": "25-50 mcg",
                            "LOE": "2"
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Other antidepressants including TCA",
                            "dose": "",
                            "LOE": "3"
                        },
                        {
                            "name": "Stimulants",
                            "dose": "",
                            "LOE": "3"
                        },
                        {
                            "name": "Lamotrigine",
                            "dose": "100-300 mg",
                            "LOE": "3"
                        },
                        {
                            "name": "Non-IV racemic ketamine",
                            "dose": "",
                            "LOE": "3"
                        },
                        {
                            "name": "Pramipexole",
                            "dose": "1-2 mg BID",
                            "LOE": "3"
                        },
                        {
                            "name": "Ziprasidone",
                            "dose": "20-80 mg BID",
                            "LOE": "3"
                        }
                    ]
                },
                {
                    "level": "Investigational",
                    "drugs": [
                        {
                            "name": "Psychedelic-assisted psychotherapy",
                            "dose": "",
                            "LOE": "3"
                        }
                    ]
                },
                {
                    "level": "Not Recommended",
                    "drugs": [
                        {
                            "name": "Cannabis",
                            "dose": "n/a",
                            "LOE": ""
                        }
                    ]
                }
            ]
        },
        {
            "name": "Psychotherapy",
            "description": "",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "Cognitive-Behavioural Therapy (CBT)",
                            "LOE": "1"
                        },
                        {
                            "name": "Interpersonal Therapy (IPT)",
                            "LOE": "1"
                        },
                        {
                            "name": "Behavioural Activation (BA)",
                            "LOE": "1"
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Cognitive Behavioural Analysis System of Psychotherapy (CBASP)",
                            "LOE": "2"
                        },
                        {
                            "name": "Mindfulness-Based Cognitive Therapy (MBCT)",
                            "LOE": "2"
                        },
                        {
                            "name": "Problem-Solving Therapy (PST)",
                            "LOE": "2"
                        },
                        {
                            "name": "Short-term Psychodynamic Psychotherapy (STPP)",
                            "LOE": "2"
                        },
                        {
                            "name": "Transdiagnostic Psychological Treatment of Emotional Disorders",
                            "LOE": "2"
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Acceptance & Commitment Therapy (ACT)",
                            "LOE": "3"
                        },
                        {
                            "name": "Long-term Psychodynamic Psychotherapy (PDT)",
                            "LOE": "3"
                        },
                        {
                            "name": "Metacognitive Therapy (MCT)",
                            "LOE": "3"
                        }
                    ]
                },
                {
                    "level": "Fourth Line",
                    "drugs": [
                        {
                            "name": "Motivational Interviewing",
                            "LOE": "4"
                        }
                    ]
                }
            ]
        },
        {
            "name": "Lifestyle",
            "description": "",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "Supervised Exercise",
                            "indication": "Mild MDE",
                            "details": "Low-Moderate Intensity, 3-4/week, minimum 9 weeks",
                            "LOE": "1"
                        },
                        {
                            "name": "Light Therapy",
                            "indication": "Seasonal (Winter) MDE",
                            "details": "10,000 lux for 30 min daily",
                            "LOE": "1"
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Light Therapy",
                            "indication": "Mild MDE",
                            "details": "",
                            "LOE": "2"
                        },
                        {
                            "name": "Adjunctive Exercise",
                            "indication": "Moderate MDE",
                            "details": "",
                            "LOE": "2"
                        },
                        {
                            "name": "Adjunctive Light Therapy",
                            "indication": "Moderate MDE",
                            "details": "",
                            "LOE": "2"
                        },
                        {
                            "name": "Adjunctive Sleep Hygiene & CBT-I",
                            "indication": "",
                            "details": "Varied diet with high content of fruit, vegetables, and fibre, and low content of saturated fat and carbohydrates",
                            "LOE": "3"
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Adjunctive Healthy Diet",
                            "indication": "",
                            "details": "",
                            "LOE": "3"
                        },
                        {
                            "name": "Adjunctive Mediterranean Diet",
                            "indication": "",
                            "details": "",
                            "LOE": "3"
                        },
                        {
                            "name": "Adjunctive Sleep Deprivation",
                            "indication": "",
                            "details": "",
                            "LOE": "3"
                        }
                    ]
                },
                {
                    "level": "Insufficient Evidence",
                    "drugs": [
                        {
                            "name": "Probiotics",
                            "indication": "",
                            "details": "",
                            "LOE": ""
                        }
                    ]
                }
            ]
        },

        {
            "name": "Digital Health Interventions",
            "description": "Various digital health interventions for mental health treatment.",
            "guidelines": [
                {
                    "level": "Guided",
                    "drugs": [
                        {
                            "name": "Good Days Ahead",
                            "RCT": "Yes",
                            "notes": "",
                            "description": "Program designed for use by a CBT therapist to provide additional CBT instruction outside of the session.",
                            "comments": "Two large RCTs showed this program reduced the need for face-to-face CBT by half, with equivalent clinical outcomes."
                        },
                        {
                            "name": "BounceBack",
                            "RCT": "",
                            "notes": "",
                            "description": "Free online CBT program with various formats: self-directed version, or with telephone-delivered lay coaching.",
                            "comments": "No RCT but a large prospective study was positive in MDD; available free in several Canadian provinces, managed by the Canadian Mental Health Association."
                        },
                        {
                            "name": "Deprexis",
                            "RCT": "Yes",
                            "notes": "Not Available in Canada",
                            "description": "Online CBT program with tailored guidance provided by an AI conversational agent; includes BA and mindfulness techniques.",
                            "comments": "Structured 12-week program designed for 90-day use; available in many countries in several languages; tested in multiple clinical trials, with a positive meta-analysis. Available in Europe and the USA."
                        },
                        {
                            "name": "MoodBeacon",
                            "RCT": "",
                            "notes": "",
                            "description": "Online guided CBT program; guidance provided by trained therapists.",
                            "comments": "Although there is no published study, this DHI was reviewed and approved for use by the Province of Ontario in 2021."
                        },
                        {
                            "name": "Pacifica/Sanvello",
                            "RCT": "Yes",
                            "notes": "Not Available in Canada",
                            "description": "Mobile- and web-based apps intended to assist users in relieving stress, anxiety, and depression. Free; offers in-app purchases.",
                            "comments": "Uses blend of CBT, mindfulness, and relaxation tools; suitable for adults and adolescents; guidance is through peer discussion in chat groups; has positive results from an RCT. Available in the USA."
                        }
                    ]
                },
                {
                    "level": "Unguided",
                    "drugs": [
                        {
                            "name": "Catch It",
                            "RCT": "",
                            "notes": "",
                            "description": "Free CBT-based mobile app, primarily uses automatic thought records and reflection exercises to address anxiety and depressive symptoms.",
                            "comments": "Developed jointly by the Universities of Liverpool and Manchester; includes a mood tracker and diary; and has an observational trial of users showing benefits."
                        },
                        {
                            "name": "Headspace",
                            "RCT": "",
                            "notes": "",
                            "description": "Popular mobile app with self-guided meditation and mindfulness techniques and some CBT approaches.",
                            "comments": "Designed for a wide variety of stress, depression and anxiety symptoms; extensively studied with good outcomes in many conditions (of mild severity), but not specifically in MDD."
                        },
                        {
                            "name": "MoodGYM",
                            "RCT": "Yes",
                            "notes": "",
                            "description": "Internet-based CBT self-help program, with very structured modules.",
                            "comments": "Most widely used platform; initially developed by Australian National University; extensively studied with good outcomes in mild depression."
                        },
                        {
                            "name": "MoodKit",
                            "RCT": "Yes",
                            "notes": "Not Available in Canada",
                            "description": "CBT-based toolkit app with detailed instructions on how to use thought records and BA.",
                            "comments": "Teaches multiple aspects of CBT and is well-integrated with mood monitoring and optional journaling. Available in the USA."
                        },
                        {
                            "name": "Spark Direct",
                            "RCT": "Yes",
                            "notes": "Not Available in Canada",
                            "description": "A mobile app providing core elements of CBT and BA in a 5-week program.",
                            "comments": "Designed for youth depression; uses interactive tasks and rewards; tested in an RCT with positive findings. Available in the USA."
                        }
                    ]
                },
                {
                    "level": "Insufficient Evidence",
                    "drugs": [
                        {
                            "name": "Probiotics",
                            "RCT": "",
                            "notes": "",
                            "description": "",
                            "comments": ""
                        }
                    ]
                }
            ]
        },

        {
            "name": "Complementary & Alternative",
            "description": "Complementary and alternative treatments for mental health disorders.",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "St. John's Wort",
                            "indication": "Mild MDE",
                            "LOE": "1"
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "Acupuncture",
                            "indication": "Mild MDE",
                            "LOE": "2"
                        },
                        {
                            "name": "St. John's Wort",
                            "indication": "Moderate MDE",
                            "LOE": "2"
                        },
                        {
                            "name": "Adjunctive Acupuncture",
                            "indication": "Moderate MDE",
                            "LOE": "2"
                        },
                        {
                            "name": "Adjunctive L-methyl folate",
                            "indication": "Mild-Moderate MDE",
                            "LOE": "2"
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Adjunctive SAM-e",
                            "indication": "Mild-Moderate MDE",
                            "LOE": "2"
                        },
                        {
                            "name": "DHEA",
                            "indication": "Mild MDE",
                            "LOE": "3"
                        },
                        {
                            "name": "Omega-3 Fatty Acids",
                            "indication": "Mild MDE",
                            "LOE": "3"
                        },
                        {
                            "name": "Saffron, Lavendar, or Roseroot",
                            "indication": "Mild MDE",
                            "LOE": "3"
                        }
                    ]
                }
            ]
        },


        {
            "name": "Neuromodulation",
            "description": "Neuromodulation treatments for mental health disorders.",
            "guidelines": [
                {
                    "level": "First Line",
                    "drugs": [
                        {
                            "name": "ECT",
                            "indication": "Severe MDE",
                            "acuteLOE": "1",
                            "maintenanceLOE": "1"
                        },
                        {
                            "name": "rTMS",
                            "indication": "TRD",
                            "acuteLOE": "1",
                            "maintenanceLOE": "3"
                        }
                    ]
                },
                {
                    "level": "Second Line",
                    "drugs": [
                        {
                            "name": "ECT",
                            "indication": "DTD",
                            "acuteLOE": "1",
                            "maintenanceLOE": "3"
                        }
                    ]
                },
                {
                    "level": "Third Line",
                    "drugs": [
                        {
                            "name": "Adjunctive tDCS",
                            "indication": "Mild-Moderate MDE",
                            "acuteLOE": "2",
                            "maintenanceLOE": "3"
                        },
                        {
                            "name": "VNS",
                            "indication": "DTD",
                            "acuteLOE": "3",
                            "maintenanceLOE": "3"
                        }
                    ]
                },
                {
                    "level": "Investigational",
                    "drugs": [
                        {
                            "name": "DBS",
                            "indication": "DTD",
                            "acuteLOE": "3",
                            "maintenanceLOE": "-"
                        },
                        {
                            "name": "MST",
                            "indication": "DTD",
                            "acuteLOE": "3",
                            "maintenanceLOE": "-"
                        }
                    ]
                }
            ]
        }
        
        
        
        
        
        
    ]
}
